What are the major opportunities in the Non-Small Cell Lung Cancer (NSCLC) market? What are the strategies for the Non-Small Cell Lung Cancer (NSCLC) market?

For detailed insights on the major opportunities and strategies in the Non-Small Cell Lung Cancer (NSCLC) market, Read More

How does the Non-Small Cell Lung Cancer (NSCLC) market relate to the overall economy and other similar markets?

For detailed insights on Non-Small Cell Lung Cancer (NSCLC)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Non-Small Cell Lung Cancer (NSCLC) market growth? SWOT analysis of the Non-Small Cell Lung Cancer (NSCLC) market.

For detailed insights on the key dynamics influencing the Non-Small Cell Lung Cancer (NSCLC) market growth and SWOT analysis of the Non-Small Cell Lung Cancer (NSCLC) industry, Read More

Non-Small Cell Lung Cancer (NSCLC) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026

Name: Non-Small Cell Lung Cancer (NSCLC) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laser Therapy, Photodynamic Therapy (PDT), Other Therapies), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Small Cell Lung Cancer (NSCLC) Market Overview

• Non-Small Cell Lung Cancer (NSCLC) market size has reached to $42.2 billion in 2025

• Expected to grow to $70.81 billion in 2030 at a compound annual growth rate (CAGR) of 11%

• Growth Driver: Rising Tobacco Consumption Fuels Growth In The Non-Small Cell Lung Cancer (NSCLC) Market

• Market Trend: FDA Accelerated Approval For Targeted Therapies Enhances Treatment Options In Non-Small Cell Lung Cancer (NSCLC)

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-Small Cell Lung Cancer (NSCLC) Market?

Non-small cell lung cancer (NSCLC) is a type of epithelial lung cancer that develops in the tissues of the lungs and is characterized by the abnormal growth of cells. It is primarily caused by long-term smoking, genetic mutations, air pollution, and secondhand smoke.

The main types of non-small cell lung cancer (NSCLC) are squamous cell carcinoma, large cell carcinoma, adenocarcinoma, and others. Squamous cell carcinoma is a type of cancer that arises from the squamous epithelial cells and can occur in other areas of the body. The various types of therapies are included, such as radiotherapy, laser therapy, photodynamic therapy (PDT), and others, with various distribution channels involved, including hospital pharmacies, online pharmacies, and others.

Non-Small Cell Lung Cancer (NSCLC) Market Global Report 2026 Market Report bar graph

What Is The Non-Small Cell Lung Cancer (NSCLC) Market Size and Share 2026?

The non-small cell lung cancer (nsclc) market size has grown rapidly in recent years. It will grow from $42.2 billion in 2025 to $46.65 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to high prevalence of smoking, exposure to air pollution, late-stage diagnosis, limited targeted therapy options, reliance on conventional chemotherapy.

What Is The Non-Small Cell Lung Cancer (NSCLC) Market Growth Forecast?

The non-small cell lung cancer (nsclc) market size is expected to see rapid growth in the next few years. It will grow to $70.81 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to rising adoption of targeted therapies and immunotherapy, increasing investment in lung cancer diagnostics, growth of personalized medicine, expansion of oncology centers and specialty clinics, development of ai-based predictive models and imaging solutions. Major trends in the forecast period include rising adoption of targeted therapy and immunotherapy, increasing use of advanced radiotherapy techniques, growing implementation of laser therapy and photodynamic therapy, expanding deployment of early diagnosis and screening programs, advancing integration of ai-powered imaging and predictive oncology.

Book your 30 minutes free consultation with our research experts

Global Non-Small Cell Lung Cancer (NSCLC) Market Segmentation

1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types

2) By Therapy: Radiotherapy, Laser Therapy, Photodynamic Therapy (PDT), Other Therapies

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Squamous Cell Carcinoma

2) By Large Cell Carcinoma: Undifferentiated Large Cell Carcinoma, Large Cell Neuroendocrine Carcinoma

3) By Adenocarcinoma: Invasive Adenocarcinoma, Bronchioloalveolar Carcinoma

4) By Other Types: Mixed Cell Type Carcinoma, Sarcomatoid Carcinoma

What Is The Driver Of The Non-Small Cell Lung Cancer (NSCLC) Market?

The increasing rate of tobacco consumption is expected to propel the growth of the non-small cell lung cancer (NSCLC) market going forward. Tobacco consumption refers to the use of tobacco products by individuals, typically in the form of smoking, chewing, or snuffing, which introduces nicotine and other chemicals into the body. Tobacco smoke contains several carcinogens that can damage the DNA (deoxyribonucleic acid) in lung cells, leading to mutations and the uncontrolled growth of cancerous cells, including non-small-cell lung cancer (NSCLC). For instance, in October 2024, according to the 2024 National Youth Tobacco Survey published by US Food and Drug Administration (USFDA), a US-based federal agency, 1.1% of all students (approximately 2.25 million) reported current use of tobacco products, with 10.1% of high school students (about 1.58 million) and 5.4% of middle school students (around 640,000) using tobacco; additionally, 2.8% of students (about 760,000) reported current use of any combustible tobacco product, while 3.0% (approximately 840,000) reported using multiple tobacco products. Therefore, the increasing rate of tobacco consumption is driving the growth of the non-small cell lung cancer (NSCLC) industry.

Key Players In The Global Non-Small Cell Lung Cancer (NSCLC) Market

Major companies operating in the non-small cell lung cancer (nsclc) market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Clovis Oncology, Revolution Medicines, Boehringer Ingelheim GmbH, Johnson & Johnson, Daiichi Sankyo Company Limited, BeiGene Ltd., DualityBio, Gilead Sciences Inc., Mirati Therapeutics Inc., Arcus Biosciences Inc., NeoImmuneTech

Global Non-Small Cell Lung Cancer (NSCLC) Market Trends and Insights

Major companies operating in the non-small cell lung cancer market are focusing on developing targeted therapies, such as FDA accelerated approval for drugs targeting specific genetic mutations, to enhance treatment options for patients. FDA accelerated approval refers to a regulatory pathway in which the U.S. Food and Drug Administration (FDA) grants earlier approval to a therapy that specifically targets a molecular or genetic abnormality in a disease, based on surrogate or intermediate clinical endpoints reasonably likely to predict clinical benefit. For instance, in July 2025, Dizal (Jiangsu) Pharmaceutical Co., Ltd., a China-based research-based biotechnology company, launched sunvozertinib (Zegfrovy) for adult patients with locally advanced or metastatic NSCLC harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy. Zegfrovy is administered orally at 200 mg once daily with food until disease progression or unacceptable toxicity. The therapy demonstrated a confirmed overall response rate of 46% and a duration of response of 11.1 months in the WU-KONG1B trial. The FDA approval also included the Oncomine Dx Express Test as a companion diagnostic to detect eligible patients. Sunvozertinib carries warnings for interstitial lung disease, gastrointestinal and dermatologic reactions, ocular toxicity, and embryo-fetal toxicity, reflecting its comprehensive safety profile.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Non-Small Cell Lung Cancer (NSCLC) Market?

In December 2023, Pfizer Inc., a US-based biopharmaceutical company providing innovative medicines including small molecules, biologics, and immunotherapies, acquired Seagen for approximately US$43 billion. Through this acquisition, Pfizer aims to strengthen its oncology pipeline, particularly in Non-Small Cell Lung Cancer, by leveraging Seagen’s world-leading antibody-drug conjugate (ADC) technology to develop next-generation cancer therapies. Seagen is a US-based biotechnology company that is actively developing and studying therapies for NSCLC.

Regional Outlook

North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Small Cell Lung Cancer (NSCLC) Market?

The non-small cell lung cancer (NSCLC) market includes revenues earned by entities by providing services such as targeted therapies, radiation therapies, imaging tests, biopsy, bronchoscopy, and lung function tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-small cell lung cancer (NSCLC) market also includes sales of chemotherapy drugs such as cisplatin, carboplatin, and pemetrexed epidermal growth factor receptor (EGFR) inhibitors such as erlotinib, afatinib, and gefitinib, as well as pain medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Small Cell Lung Cancer (NSCLC) Market Report 2026?

The non-small cell lung cancer (nsclc) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-small cell lung cancer (nsclc) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Non-Small Cell Lung Cancer (NSCLC) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$46.65 billion
Revenue Forecast In 2035	$70.81 billion
Growth Rate	CAGR of 10.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Therapy, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Clovis Oncology, Revolution Medicines, Boehringer Ingelheim GmbH, Johnson & Johnson, Daiichi Sankyo Company Limited, BeiGene Ltd., DualityBio, Gilead Sciences Inc., Mirati Therapeutics Inc., Arcus Biosciences Inc., NeoImmuneTech
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Non-Small Cell Lung Cancer (NSCLC) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Non-Small Cell Lung Cancer (NSCLC) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Non-Small Cell Lung Cancer (NSCLC) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Non-Small Cell Lung Cancer (NSCLC) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Digitalization, Cloud, Big Data & Cybersecurity

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Biotechnology, Genomics & Precision Medicine

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Therapy And Immunotherapy

4.2.2 Increasing Use Of Advanced Radiotherapy Techniques

4.2.3 Growing Implementation Of Laser Therapy And Photodynamic Therapy

4.2.4 Expanding Deployment Of Early Diagnosis And Screening Programs

4.2.5 Advancing Integration Of Ai-Powered Imaging And Predictive Oncology

5. Non-Small Cell Lung Cancer (NSCLC) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Oncology Clinics

5.3 Cancer Treatment Centers

5.4 Diagnostic Imaging Centers

5.5 Pharmacy Chains

6. Non-Small Cell Lung Cancer (NSCLC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Small Cell Lung Cancer (NSCLC) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-Small Cell Lung Cancer (NSCLC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Non-Small Cell Lung Cancer (NSCLC) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Non-Small Cell Lung Cancer (NSCLC) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Non-Small Cell Lung Cancer (NSCLC) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Small Cell Lung Cancer (NSCLC) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Small Cell Lung Cancer (NSCLC) Market Segmentation

9.1. Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types

9.2. Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radiotherapy, Laser Therapy, Photodynamic Therapy (PDT), Other Therapies

9.3. Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Online Pharmacy, Other Distribution Channels

9.4. Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Squamous Cell Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Squamous Cell Carcinoma

9.5. Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Large Cell Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Undifferentiated Large Cell Carcinoma, Large Cell Neuroendocrine Carcinoma

9.6. Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Invasive Adenocarcinoma, Bronchioloalveolar Carcinoma

9.7. Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mixed Cell Type Carcinoma, Sarcomatoid Carcinoma

10. Non-Small Cell Lung Cancer (NSCLC) Market Regional And Country Analysis

10.1. Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market

11.1. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Small Cell Lung Cancer (NSCLC) Market

12.1. China Non-Small Cell Lung Cancer (NSCLC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Small Cell Lung Cancer (NSCLC) Market

13.1. India Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Small Cell Lung Cancer (NSCLC) Market

14.1. Japan Non-Small Cell Lung Cancer (NSCLC) Market Overview

14.2. Japan Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Small Cell Lung Cancer (NSCLC) Market

15.1. Australia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Small Cell Lung Cancer (NSCLC) Market

16.1. Indonesia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Small Cell Lung Cancer (NSCLC) Market

17.1. South Korea Non-Small Cell Lung Cancer (NSCLC) Market Overview

17.2. South Korea Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Small Cell Lung Cancer (NSCLC) Market

18.1. Taiwan Non-Small Cell Lung Cancer (NSCLC) Market Overview

18.2. Taiwan Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Small Cell Lung Cancer (NSCLC) Market

19.1. South East Asia Non-Small Cell Lung Cancer (NSCLC) Market Overview

19.2. South East Asia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market

20.1. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market Overview

20.2. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Small Cell Lung Cancer (NSCLC) Market

21.1. UK Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Small Cell Lung Cancer (NSCLC) Market

22.1. Germany Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Small Cell Lung Cancer (NSCLC) Market

23.1. France Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Small Cell Lung Cancer (NSCLC) Market

24.1. Italy Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Small Cell Lung Cancer (NSCLC) Market

25.1. Spain Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market

26.1. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market Overview

26.2. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Small Cell Lung Cancer (NSCLC) Market

27.1. Russia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Small Cell Lung Cancer (NSCLC) Market

28.1. North America Non-Small Cell Lung Cancer (NSCLC) Market Overview

28.2. North America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Small Cell Lung Cancer (NSCLC) Market

29.1. USA Non-Small Cell Lung Cancer (NSCLC) Market Overview

29.2. USA Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Small Cell Lung Cancer (NSCLC) Market

30.1. Canada Non-Small Cell Lung Cancer (NSCLC) Market Overview

30.2. Canada Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Small Cell Lung Cancer (NSCLC) Market

31.1. South America Non-Small Cell Lung Cancer (NSCLC) Market Overview

31.2. South America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Small Cell Lung Cancer (NSCLC) Market

32.1. Brazil Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Small Cell Lung Cancer (NSCLC) Market

33.1. Middle East Non-Small Cell Lung Cancer (NSCLC) Market Overview

33.2. Middle East Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Small Cell Lung Cancer (NSCLC) Market

34.1. Africa Non-Small Cell Lung Cancer (NSCLC) Market Overview

34.2. Africa Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Segmentation By Therapy, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Small Cell Lung Cancer (NSCLC) Market Regulatory and Investment Landscape

36. Non-Small Cell Lung Cancer (NSCLC) Market Competitive Landscape And Company Profiles

36.1. Non-Small Cell Lung Cancer (NSCLC) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Non-Small Cell Lung Cancer (NSCLC) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Non-Small Cell Lung Cancer (NSCLC) Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Non-Small Cell Lung Cancer (NSCLC) Market Other Major And Innovative Companies

Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Clovis Oncology, Revolution Medicines, Boehringer Ingelheim GmbH, Johnson & Johnson, Daiichi Sankyo Company Limited, BeiGene Ltd.

38. Global Non-Small Cell Lung Cancer (NSCLC) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Small Cell Lung Cancer (NSCLC) Market

40. Non-Small Cell Lung Cancer (NSCLC) Market High Potential Countries, Segments and Strategies

40.1 Non-Small Cell Lung Cancer (NSCLC) Market In 2030 - Countries Offering Most New Opportunities

40.2 Non-Small Cell Lung Cancer (NSCLC) Market In 2030 - Segments Offering Most New Opportunities

40.3 Non-Small Cell Lung Cancer (NSCLC) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Non-Small Cell Lung Cancer (NSCLC) Market, Overview Of Key Products - Product Examples

Table 2: Global Non-Small Cell Lung Cancer (NSCLC) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Non-Small Cell Lung Cancer (NSCLC) Market, Supply Chain Analysis

Table 4: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Raw Material Providers

Table 5: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Resource Providers

Table 6: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Manufacturers (Suppliers)

Table 7: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Distributors And Channel Partners

Table 8: Global Non-Small Cell Lung Cancer (NSCLC) Market, Key Technologies & Future Trends

Table 9: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Trends

Table 10: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major End Users

Table 11: Global Non-Small Cell Lung Cancer (NSCLC) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Non-Small Cell Lung Cancer (NSCLC) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Non-Small Cell Lung Cancer (NSCLC) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Non-Small Cell Lung Cancer (NSCLC) Market - TAM, US$ Billion, 2025

Table 15: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Squamous Cell Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Large Cell Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Non-Small Cell Lung Cancer (NSCLC) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Non-Small Cell Lung Cancer (NSCLC) Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: F. Hoffmann-La Roche AG Financial Performance

Table 100: Merck & Co. Inc. Financial Performance

Table 101: AbbVie Inc. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Global Non-Small Cell Lung Cancer (NSCLC) Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Non-Small Cell Lung Cancer (NSCLC) Market, Competitive Dashboard

Table 105: Global Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Table 108: Global, Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Non-Small Cell Lung Cancer (NSCLC) Market, Overview Of Key Products - Product Examples

Figure 2: Global Non-Small Cell Lung Cancer (NSCLC) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Non-Small Cell Lung Cancer (NSCLC) Market, Supply Chain Analysis

Figure 4: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Raw Material Providers

Figure 5: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Resource Providers

Figure 6: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Manufacturers (Suppliers)

Figure 7: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Distributors And Channel Partners

Figure 8: Global Non-Small Cell Lung Cancer (NSCLC) Market, Key Technologies & Future Trends

Figure 9: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major Trends

Figure 10: Global Non-Small Cell Lung Cancer (NSCLC) Market, Major End Users

Figure 11: Global Non-Small Cell Lung Cancer (NSCLC) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Non-Small Cell Lung Cancer (NSCLC) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Non-Small Cell Lung Cancer (NSCLC) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Non-Small Cell Lung Cancer (NSCLC) Market - TAM, US$ Billion, 2025

Figure 15: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Squamous Cell Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Large Cell Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Non-Small Cell Lung Cancer (NSCLC) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Non-Small Cell Lung Cancer (NSCLC) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Non-Small Cell Lung Cancer (NSCLC) Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: F. Hoffmann-La Roche AG Financial Performance

Figure 100: Merck & Co. Inc. Financial Performance

Figure 101: AbbVie Inc. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Global Non-Small Cell Lung Cancer (NSCLC) Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Non-Small Cell Lung Cancer (NSCLC) Market, Competitive Dashboard

Figure 105: Global Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Figure 108: Global, Non-Small Cell Lung Cancer (NSCLC) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Global Outlook – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laser Therapy, Photodynamic Therapy...

Small Cell Lung Cancer Therapeutics Market Report 2026 - Global Outlook – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy,...

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Global Outlook – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laser Therapy, Photodynamic Therapy...

Advanced Renal Cell Carcinoma Treatment Market Report 2026 - Global Outlook – By Treatment (Biologics, Radiation Therapy), By Route Of Administration (Parental, Oral, Other Routes Of Administration), By End User (Hospita...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs ), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung canc...

Frequently Asked Questions

How big is the Non-Small Cell Lung Cancer (NSCLC) Market?

The Non-Small Cell Lung Cancer (NSCLC) market was valued at $42.2 billion in 2025, increased to $46.65 billion in 2026, and is projected to reach $70.81 billion by 2030. request a sample here

What is the Non-Small Cell Lung Cancer (NSCLC) market growth?

The global Non-Small Cell Lung Cancer (NSCLC) market is expected to grow at a CAGR of 11.0% from 2026 to 2035 to reach $70.81 billion by 2035. request a sample here

Who are the key players in Non-Small Cell Lung Cancer (NSCLC) market?

Some Key Players in the Non-Small Cell Lung Cancer (NSCLC) market Include, Pfizer Inc., F. Hoffmann‑La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol‑Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Clovis Oncology, Revolution Medicines, Boehringer Ingelheim GmbH, Johnson & Johnson, Daiichi Sankyo Company Limited, BeiGene Ltd., DualityBio, Gilead Sciences Inc., Mirati Therapeutics Inc., Arcus Biosciences Inc., NeoImmuneTech . request a sample here

What is the anticipated growth trend for the Non-Small Cell Lung Cancer (NSCLC) market?

Major trend in this market includes: FDA Accelerated Approval For Targeted Therapies Enhances Treatment Options In Non-Small Cell Lung Cancer (NSCLC). For further insights on this market. request a sample here

Which region has the most growth potential in the Non-Small Cell Lung Cancer (NSCLC) market?

North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (nsclc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 market?

Major companies operating in the Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 market are Major companies operating in the non-small cell lung cancer (nsclc) market are Pfizer Inc., F. Hoffmann‑La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol‑Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Clovis Oncology, Revolution Medicines, Boehringer Ingelheim GmbH, Johnson & Johnson, Daiichi Sankyo Company Limited, BeiGene Ltd., DualityBio, Gilead Sciences Inc., Mirati Therapeutics Inc., Arcus Biosciences Inc., NeoImmuneTech request a sample here.

Which region has the most growth potential in the Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 market?